MBL ELISA Kit
Mannan-binding lectin (MBL) is an important factor in innate immunity.The MBL Oligomer ELISA (KIT 029) has over the years become the gold standard for MBL determination.
MBL is a key test in the assessment of immune deficiencies. With more than 12% of the average population MBL deficient doctors should include MBL testing in their practice parameters with:
- Children with recurrent infections
- Immunosuppressed patients
- Patients with autoimmune diseases
Rat NGAL ELISA Kit launched
NGAL determination allows kidney injury to be detected almost as soon as it occurs. Rats are among the most frequently used laboratory animals for research on kidney damage. The rat NGAL test can thus be used in the development of new treatments for kidney damage, to detect nephrotoxic side effects of new drugs, and for basic science research on kidney injury and kidney diseases.
It is therefore expected that the use of NGAL as a toxicological marker of kidney damage in rats could prove to be of considerable importance in the preclinical evaluation of new pharmacological products, as it is much cheaper and easier to determine NGAL than to carry out a microscopic examination of the kidney itself, which is the typical experimental end-point today.
Human IgE (non-immune)
This antigen is an affinity purified, fully human IgE antibody, produced in vitro from a monoclonal hybridoma. The monoclonal source of IgE ensures high reproducibility and is free from other immunoglobulins. The very low batch-to-batch variation makes this antibody well suited as a standard in IgE quantifying assays. Other applications include immunochemistry and cellular immunology research.
An Important addition to our complement antibody collection: Anti-C5b-9 (human) antibody
BioPorto Diagnostics is happy to offer a new monoclonal antibody DIA 011-01, for measurement of the terminal complement complex (TCC), which is formed in the terminal step of the complement cascade.
Anti-NGAL (monkey) antibody available
The new monoclonal antibody ABS 038-23 is specific for the monkey NGAL and is selected specifically for the ability to form an ELISA sandwich pair with biotinylated HYB 211-02.
The antibody pair is for research use only and can assay early nephrotoxicity of pharmacological compound in monkeys on an ELISA platform. It is expected to find use in the area of pre-clinical studies and acute kidney injury research.
